LBRX

Lb Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 0/10
  • Momentum 0/10
Lb Pharmaceuticals sales and earnings growth
LBRX Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y 0.00%
  • FCF Y/Y 0.00%
Lb Pharmaceuticals gross and profit margin trends
LBRX Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 0.00%
Lb Pharmaceuticals net debt vs free cash flow
LBRX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage 0.0

Lb Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗